Pfizer is planning to get as many naive people as possible to take an annual COVID-19 injection. The Food and Drug Administration is expected to approve this new booster shot as early as this month.
Pfizer CEO Albert Bourla said during an investor call Tuesday that the FDA could authorize the company’s new COVID-19 booster shot by the end of the month. This is moving the globe closer to a system of regular flu-like”vaccinations” with mRNA technology.
Bourla said he and his colleagues (other experts and rulers) expect “a new COVID wave to start in the U.S. this fall” and want the new version of the vaccine to be available prior to that.
According to Forbes, in June, Pfizer, along with its German partner BioNTech, asked the FDA to approve a new version of its Covid-19 vaccine booster designed to protect against XBB.1.5, a coronavirus subvariant that emerged in late 2022.
Even though the mainstream media says XBB.1.5 is no longer the dominant strain, having been usurped by XBB.1.6, this annual booster can help with both variants. According to the Centers for Disease Control and Prevention, experts say the two mutations are similar enough that a new booster should protect against both (XBB.1.5 represented 12.3% of all new cases in late July while XBB.1.6 represented 14.8%, according to the CDC’s data).
The CDC will make the final decision on who they want to be injected with the updated boosters, but that announcement likely won’t come until after the FDA authorizes them. The most recent boosters released in the fall of 2022 were eventually recommended by the CDC for everyone above the age of six.
Only 17% of the U.S. population has received a fall 2022 booster shot that was updated for the Omicron variant, according to the CDC, it’s unclear how many Americans will choose to adopt the latest booster, but it’s not likely to be a lot. In fact, 17% seems high for last year’s booster.
What we can expect, is the ruling class and big pharma to begin a massive propaganda campaign to try to get more people injected with mRNA technology.